SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
RF Acquisition Corp III entered into a Business Combination Agreement with HCC Healthcare on July 9, 2026, whereby HCC Healthcare will become a publicly traded company on Nasdaq with an approximately $500 million equity valuation, with closing expected in Q4 2026.
View raw filing on EDGAR →The filing discloses the completion of a material disposition of a real estate asset—the Franklin Crossing shopping center—for $27,000,000 in purchase price, generating net proceeds of approximately $25,400,000 and a net gain of approximately $19,500,000. This is a completed sale transaction that materially affects FREIT's asset base and financial position, fitting squarely within the ma_activity category (Item 1.01 covers entry into material definitive agreements, and this section reports the consummation of the previously-announced Purchase and Sale Agreement).
View raw filing on EDGAR →BRT Apartments entered into an agreement to acquire The Waterford on Piedmont, a 153-unit multifamily property in Atlanta for approximately $35 million. This is a material acquisition of a real estate asset that will expand the company's portfolio. The filing discloses the purchase price, financing structure, expected closing date, and the target property's financial performance, all hallmarks of M&A activity disclosure under Item 1.01 or 2.01.
View raw filing on EDGAR →The disclosure announces ProLogium's filing of a Form F-4 registration statement with the SEC as part of an ongoing de-SPAC merger transaction between TDAC and ProLogium that was originally announced on May 27, 2026. The press release explicitly states this filing represents "continuing momentum towards merger" and describes it as driving "the companies forward towards a successful execution of the de-SPAC transaction." This is a material milestone in a merger/change-of-control transaction.
View raw filing on EDGAR →Charles & Colvard completed the sale of substantially all its assets to AJS Creations, Inc. for $2,700,000 in cash following Bankruptcy Court approval on July 1, 2026. This asset disposition represents a fundamental change in the company's structure and the culmination of a court-supervised auction process.
View raw filing on EDGAR →This exhibit announces a definitive merger agreement between Chemomab Therapeutics and Scipher Medicine Corporation, a material acquisition/change of control transaction. The press release discloses entry into the merger agreement, the stock-for-stock transaction structure, ownership percentages (32% Chemomab, 68% Scipher post-closing), a concurrent $30 million private placement, expected closing in Q4 2026, and contingent value rights for Chemomab shareholders. This is a classic material M&A event requiring disclosure under Item 1.01 or 2.01 of an 8-K equivalent.
View raw filing on EDGAR →The filing discloses termination of two material definitive agreements: (1) the GSK Collaboration and License Agreement for development of investigational monoclonal antibodies latozinemab and nivisnebart, effective January 2, 2027, following failed Phase 3 and Phase 2 clinical trials; and (2) the Loan and Security Agreement with Hercules Capital, which the Company repaid in full ($10.4M principal plus interest and charges) on July 8, 2026. The GSK termination represents a material change in the Company's pipeline and strategic partnership following clinical trial failures, while the loan repayment signals a significant capital event. While Item 1.02 covers termination of material agreements, the substance here—loss of a major collaboration and debt restructuring—most closely aligns with material M&A/strategic activity, though `financial_other` (debt repayment) or `operational_other` (partnership termination) could also apply.
View raw filing on EDGAR →The filing discloses the Board's recommendation regarding a revised unsolicited tender offer from Zodiac Partners II to acquire all outstanding shares at $0.84 per share. This is a material acquisition activity (change of control attempt) that directly affects shareholders' rights and the company's future. The Board's formal rejection and recommendation that stockholders not tender their shares is a significant corporate event requiring disclosure under Item 7.01 and Schedule 14D-9 filing obligations.
View raw filing on EDGAR →Vistance Networks completed the sale of its RUCKUS reporting segment to Belden, Inc. for $1.846 billion in cash on July 1, 2026. This is a material disposition of assets representing a strategic shift that meets the criteria for discontinued operations under ASC 205-20. The transaction is disclosed under Item 2.01 (Completion of Acquisition or Disposition of Assets) and involves a significant portion of the company's business, making it a core M&A activity event.
View raw filing on EDGAR →Catalyst Pharmaceuticals stockholders approved the anticipated merger with Angelini Pharma at a special meeting held on July 8, 2026, with the Merger Proposal receiving approximately 98.8% of votes cast (97,340,180 votes in favor). Directors' conditional resignations were disclosed in connection with the anticipated consummation of the Merger Agreement dated May 6, 2026, which constitutes a material acquisition and change of control event.
View raw filing on EDGAR →The filing discloses a material modification to a previously announced business combination between CEPO and BSTR Holdings, Inc. The parties have agreed that they "will not complete the proposed business combination on the terms initially set forth in the business combination agreement, dated July 16, 2025" and are "discussing a potential revised structure and amended terms." The extraordinary general meeting scheduled for July 10, 2026 has been indefinitely postponed, and the pending private placements will not be required to close. This constitutes a material change to the M&A transaction structure and timeline that would significantly affect investor expectations.
View raw filing on EDGAR →Presidio Production Company completed the acquisition of Canyon Creek oil and gas properties and assets from multiple sellers (including Vortus Investments, Alchemist, Pivotal, East Dennis, Harvard, and FBF) for approximately $83 million in total consideration, consisting of approximately $52.5 million in cash and 1,962,240 shares of Class A common stock. The company characterized this as its second acquisition as a public company and the first use of its ABS Warehouse Facility.
View raw filing on EDGAR →Cantor Equity Partners II, Inc. completed a business combination merger with CEPT Merger Sub, resulting in a change of control. The merger subsidiary became a wholly-owned subsidiary of Pubco (PINECREST MERGER SUB), and 6,842,508 shares were redeemed in connection with the transaction.
View raw filing on EDGAR →Bleichroeder Acquisition Corp. III consummated a $345 million IPO on July 8, 2026, entering into multiple material definitive agreements including an underwriting agreement, warrant agreement, and private placement agreements to establish the capital-raising infrastructure for a future business combination.
View raw filing on EDGAR →Securitize, Inc. completed a business combination with CEPT (a shell company) on July 1, 2026, resulting in a publicly traded combined entity trading on NYSE under ticker 'SECZ.' The transaction involved entry into material definitive agreements (lock-up, registration rights, and indemnification agreements), a reverse recapitalization with a change of control, and material modifications to security holders' rights through an amended and restated certificate of incorporation.
View raw filing on EDGAR →Real Asset Acquisition Corp. (RAAQ) completed a business combination merger with IQM, resulting in a change of control. The transaction involved entry into material definitive agreements including a Registration Rights Agreement and Warrant Assignment Agreement on the Closing Date, with the merger becoming effective on July 8, 2026.
View raw filing on EDGAR →BTQ Technologies announces the completion of its acquisition of QPerfect SA, a French quantum computing company. The news release explicitly states "BTQ Technologies Completes Acquisition of QPerfect" and confirms "Following the closing, QPerfect is now a wholly owned subsidiary of BTQ." This is a material acquisition that adds significant technology assets (MIMIQ quantum emulator, Digital Twin capabilities, and Quantum Logical Unit) and establishes a European R&D hub in Strasbourg, directly advancing BTQ's strategic mission.
View raw filing on EDGAR →Byrna Technologies entered into a definitive Asset Purchase Agreement on July 7, 2026, to acquire substantially all assets of HERO Defense Systems, LLC for $1.25 million in total consideration ($625,000 cash and $625,000 in restricted shares) plus performance-based royalties. The acquisition is expected to close within 30 days and expands Byrna's product portfolio and addressable market.
View raw filing on EDGAR →ReposiTrak entered into Stock Purchase Agreements on July 1, 2026 to acquire 4,709,837 shares of SPAR Group, Inc. common stock (31.3% stake) for approximately $3.3 million in aggregate consideration, representing a material strategic equity investment.
View raw filing on EDGAR →The filing discloses entry into and consummation of an asset purchase agreement on July 1, 2026, whereby the Company's subsidiary Live Blue acquired substantially all assets of Sunrise Paddleboards (a paddleboarding and kayaking business) in exchange for 42 million shares of common stock. This is a material acquisition transaction under Item 1.01, representing a significant business combination that would materially affect investor assessment of the registrant's operations and capital structure.
View raw filing on EDGAR →The filing discloses termination of a Business Combination Agreement with United Hydrogen Group Inc., originally entered into on June 19, 2024 and amended June 6, 2025. Item 1.02 explicitly states the agreement terminated on July 7, 2026 pursuant to Section 9.1(b) due to the outside date passing without consummation. This is a material M&A event—the termination of a proposed business combination—that would significantly affect investor assessment of the registrant's strategic direction and capital structure.
View raw filing on EDGAR →Evolus entered into an exclusive License, Supply and Distribution Agreement with IBSA on July 7, 2026, granting exclusive rights to develop, commercialize, and distribute Profhilo® in the United States. The 15-year initial term agreement with renewal options expands the company's injectable portfolio into the skin-quality segment and includes minimum purchase requirements structured with a transfer-price model designed to support gross margins consistent with the company's long-term financial framework.
View raw filing on EDGAR →ECARX entered into a share exchange agreement with Qualcomm Ventures LLC on July 7, 2026, whereby Qualcomm will acquire 10,329,562 Class A ordinary shares at a VWAP-determined price, with settlement via transfer of Qualcomm's equity interest in DreamSmart. This constitutes a material acquisition-related transaction involving a significant equity stake and intellectual property rights, expected to close in August 2026.
View raw filing on EDGAR →Dream Finders Homes has submitted a revised all-cash acquisition proposal to Beazer Homes USA, Inc. for $32.00 per share, representing a 70% premium to Beazer's undisturbed share price. The filing discloses entry into material acquisition activity—specifically a proposed change of control transaction involving the acquisition of all outstanding shares of Beazer. This is a core M&A event that would materially affect investor assessment of both companies' strategic direction and financial position.
View raw filing on EDGAR →Azenta completed the sale of its B Medical Systems business to Thelema S.à r.l. for $63 million in cash on July 1, 2026, with $35 million funded via a vendor loan. The transaction involved entry into material definitive agreements (Vendor Loan Agreement, Share Pledge Agreement, and Deed of Amendment) and has been classified as a significant disposition under Item 2.01, with B Medical reclassified as a discontinued operation.
View raw filing on EDGAR →Onfolio Holdings entered into a binding Letter of Intent to acquire Paramount Helium LLC in a merger or business combination, whereby the Company will issue 50 million shares of convertible preferred stock and receive rights to acquire Proton Green's senior secured indebtedness. The transaction includes a name change to Paramount Helium Corporation, board restructuring, and executive leadership changes, positioning the Company in the $122 billion global industrial gas market with access to an estimated $3 billion US-based helium resource.
View raw filing on EDGAR →Nocera entered into a binding letter of intent on July 6, 2026, to acquire up to 9.99% of INERGX Energy Optimisation Ltd, a strategic equity investment in an energy storage and power platform company, with consideration consisting of cash and/or Company common stock. This transaction is positioned as a significant milestone in Nocera's transformation strategy into a diversified technology holding company.
View raw filing on EDGAR →Tarsus Pharmaceuticals completed its acquisition of iRenix Medical, Inc., a clinical-stage ophthalmic biopharmaceutical company, for approximately $75 million in upfront consideration ($37.5 million cash and 607,093 shares of stock) plus up to $490 million in milestone payments and revenue sharing. The transaction includes the acquisition of IRX-101, a late-stage asset that expands Tarsus's pipeline in eye care.
View raw filing on EDGAR →The filing discloses the scheduling of an Extraordinary General Meeting for July 29, 2026, to approve a previously announced business combination between BCAR (a SPAC) and Exascale Labs Inc. The merger agreement was entered into on January 11, 2026, and the combined company is expected to operate as Exascale Labs Holdings Inc. trading under ticker "XLAB." This is a material acquisition/change of control event requiring shareholder approval, consistent with Item 8.01 disclosure of M&A activity.
View raw filing on EDGAR →Blue Owl Real Estate Net Lease Trust's subsidiary completed the acquisition of Sila Realty Trust, Inc. on July 1, 2026, for approximately $2.4 billion in cash consideration ($30.38 per share), with Sila integrated as an indirect subsidiary of the Operating Partnership.
View raw filing on EDGAR →Unitil Corporation completed the acquisition of Aquarion Water Company of New Hampshire, Inc. and Abenaki Water Co., Inc. from Aquarion Water Authority for $55.8 million (including $13.7 million of assumed debt) on June 30, 2026. The acquisition adds approximately 11,000 water customers and a $47 million rate base, expanding Unitil's regulated utility operations and is expected to be earnings accretive.
View raw filing on EDGAR →Coty entered into a License Termination and Transition Agreement with Kering to terminate the Gucci Beauty license early (June 30, 2027 vs. original expiration), receiving approximately $400 million in consideration ($250 million at signing, $150 million deferred). This constitutes a material disposition of a significant business asset—Gucci Beauty is a major revenue driver that Coty has grown 60% since 2019—and involves a substantial cash payment and strategic redeployment of capital. The transaction materially affects the registrant's scope and financial position.
View raw filing on EDGAR →First Majestic has entered into a definitive agreement to sell its 100%-owned San Martin Silver Mine to Flextronics for total proceeds of US$90 million. This is a material disposition of a significant asset—a past-producing silver and gold mine—representing a substantial divestiture that would affect a reasonable investor's assessment of the company's asset base and strategic direction. The transaction is structured with upfront and deferred payments and is subject to Mexican Antitrust approval, with expected closing in Q4 2026.
View raw filing on EDGAR →Iridium Communications completed its acquisition of the remaining 61% equity interests in Aireon Holdings LLC on July 2, 2026, for approximately $366.7 million, resulting in full ownership of Aireon. The acquisition combines Aireon's space-based ADS-B air traffic surveillance system with Iridium's satellite communications network and positioning, navigation, and timing capabilities, materially expanding Iridium's role in the aviation ecosystem.
View raw filing on EDGAR →Ivanhoe Electric entered into an Amended and Restated Shareholders Agreement on July 7, 2026, governing a 50/50 joint venture with Saudi Arabian Mining Company (Maaden) for mineral exploration in Saudi Arabia. The agreement materially modifies the prior 2023 agreement by extending the exploration term to ten years (through July 6, 2033), expanding the Joint Venture's ability to acquire licenses directly, and restructuring governance and operational authority. This constitutes a material definitive contract modification affecting the Company's strategic partnership and exploration rights in a significant geographic region, warranting disclosure under Item 1.01.
View raw filing on EDGAR →MacroGenics completed the sale of its GMP manufacturing operations and CDMO business to Bora Pharmaceuticals for $122.5 million in cash (plus up to $5 million in contingent consideration) effective June 30, 2026. The transaction involves the transfer of approximately 140 employees and two manufacturing facilities, representing a material disposition of a significant business segment and a strategic shift toward a clinical-stage company focused on internal pipeline development.
View raw filing on EDGAR →The filing discloses that the HSR Waiting Period for the proposed merger between Taylor Morrison and Berkshire Hathaway expired on July 6, 2026, removing a key closing condition. This represents material progress toward completion of a change-of-control transaction that was previously disclosed on May 31, 2026. The merger remains subject to shareholder approval and other regulatory approvals, but the HSR clearance is a significant milestone in the M&A process that would materially affect investor assessment of transaction likelihood and timing.
View raw filing on EDGAR →Olaplex completed a merger on July 7, 2026, in which common shareholders received $2.06 per share in cash consideration and the company became a wholly owned subsidiary of the acquirer. The transaction had an equity value of approximately $1.4 billion, involved repayment of $357.6 million in outstanding debt and termination of the Credit Agreement, and resulted in delisting from Nasdaq and termination of SEC registration.
View raw filing on EDGAR →MasTec entered into a Share Purchase Agreement to acquire Electrical Specialists, Inc. (Superior Group), a premier full-service electrical contractor, for approximately $475 million in stock consideration, representing approximately 1.5% dilution.
View raw filing on EDGAR →ResMed entered into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners for $490 million in an all-cash transaction expected to close in Q1 fiscal 2027. The disposition represents approximately $220 million in annual revenue and $55 million in non-GAAP operating profit, reflecting a strategic portfolio shift toward high-growth sleep and connected care markets. The company plans to return net proceeds to shareholders via an accelerated share repurchase program.
View raw filing on EDGAR →Banzai International completed the acquisition of substantially all assets of ConnectAndSell, Inc. on July 2, 2026, pursuant to an Asset Purchase Agreement, with total consideration of approximately $13.2 million including cash, stock, a promissory note, deferred payments, and earn-out consideration, plus assumption of liabilities.
View raw filing on EDGAR →Getty Images terminated its Agreement and Plan of Merger with Shutterstock, Inc. on July 7, 2026, following the Board's June 30, 2026 resolution not to proceed with the transaction. The termination of a material acquisition agreement is a significant M&A event that materially affects the registrant's strategic direction and financial position, particularly given the subsequent redemption of the Senior Secured Notes triggered by the merger's failure.
View raw filing on EDGAR →Perpetuals.com has signed a non-binding term sheet to explore the potential acquisition of AI Financial Corporation's subsidiary Alt5 Sigma Canada, Inc. This constitutes entry into a material acquisition transaction. Although the term sheet is non-binding and due diligence is ongoing, the announcement of a proposed acquisition of a profitable subsidiary is a material event that would affect a reasonable investor's assessment of the registrant's strategic direction and capital deployment.
View raw filing on EDGAR →Osprey Acquisition Corp. III consummated its initial public offering on July 2, 2026, raising $300.15 million in gross proceeds through the issuance of 30,015,000 units at $10.00 per unit. Each unit comprises one Class A ordinary share and one-third of a redeemable warrant exercisable at $11.50. The IPO establishes the capital base for the SPAC's future business combination activities.
View raw filing on EDGAR →This 8-K discloses the consummation of a $230 million initial public offering by Viking Acquisition Corp. II on July 6, 2026, including entry into multiple material definitive agreements (underwriting agreement, warrant agreements, insider letter agreement, registration rights agreement, and indemnity agreements). While the primary event is an IPO capital raise, the filing is structured around Item 1.01 (Entry into Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), which are financial/capital events. However, the core transaction—a blank-check SPAC raising capital to pursue a future business combination—is most appropriately classified as a material capital/financing event. The closest taxonomy fit is `ma_activity` given the material nature of the IPO and the company's stated purpose to effect a merger or business combination, though this is technically a capital raise rather than an M&A transaction itself.
View raw filing on EDGAR →House of Doge Inc. completed its merger with Brag House Holdings, Inc. (formerly NASDAQ: TBH) on June 30, 2026, resulting in a material change of control. The combined company was renamed House of Doge Inc., began trading under ticker 'HODO' on Nasdaq on July 1, 2026, with former HOD stockholders owning approximately 90.66% of issued and outstanding shares (83.32% on a fully diluted basis).
View raw filing on EDGAR →CareDx completed two material M&A transactions: (1) sale of CareDx AB and lab products business to Eurobio Scientific for $171.7 million cash on June 30, 2026, and (2) acquisition of Naveris, Inc. for $161.8 million cash plus up to $100 million in contingent consideration on July 1, 2026. These transactions materially reshape CareDx's business portfolio by divesting its European lab products business while acquiring a high-growth specialty oncology diagnostics platform (NavDx) that expands the addressable market to $12+ billion.
View raw filing on EDGAR →The filing discloses the completed sale of the 357-room Marriott Fremont Silicon Valley hotel for $53.0 million in cash on July 1, 2026, pursuant to an Agreement of Purchase and Sale dated June 19, 2026. This is a material disposition of a hotel asset by Ashford Hospitality Trust, a REIT, and is properly classified under Item 2.01 (Completion of Acquisition or Disposition of Assets). The transaction is material to investors as it represents a significant reduction in the company's asset base and includes pro forma financial statements showing the removal of the property's revenue and expenses.
View raw filing on EDGAR →Axos Financial entered into a definitive agreement to acquire Arc Technologies, Inc., a financial technology platform. This is a material acquisition disclosed under Item 8.01 (Other Events). Although the company states the transaction is "not expected to have a material impact to results of operations or financial condition," the entry into a definitive agreement for an acquisition is itself a material event that would affect a reasonable investor's assessment of the registrant's strategic direction and capital deployment. The press release emphasizes Arc's AI capabilities, technology platform, and strategic fit with Axos' digital banking strategy.
View raw filing on EDGAR →The filing discloses the completion of a merger between Envirotech Vehicles and Azio AI Corporation, closed on July 2, 2026. The press release explicitly states "the successful completion of its merger with Azio AI Corporation" and describes the transaction structure, merger consideration (2,655,157 shares of common stock and 973,450 shares of preferred stock), and the combined company's strategic pivot to AI infrastructure. This is a material acquisition that fundamentally transforms the registrant's business and capital structure.
View raw filing on EDGAR →